Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX)

3 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") as of Q4 2023.
Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 80.7K shares of 93.8M outstanding shares and own 0.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.35M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (5.04M shares), FMR LLC (4.04M shares), STATE STREET CORP (3.56M shares), VANGUARD GROUP INC (3.5M shares), Point72 Asset Management, L.P. (3.42M shares), WELLINGTON MANAGEMENT GROUP LLP (3.25M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.01M shares), JENNISON ASSOCIATES LLC (2.55M shares), and T. Rowe Price Investment Management, Inc. (2.42M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.